the organism company ginkgo bioworks engineers new organisms to solve challenges across a range of industries from fuels to pharmaceutical production. our biological engineers make use of an in-house pipeline of synthetic biology technologies to design, build, and test new organisms.

Breakdown of combined holdings in all Ark funds. See current position, past trades, and weighting changes

⚖️Weighting	🧢Market Cap
2.46%	$4.72b
🏋️‍♀️Weight Rank Across All Funds	🌏Country
15	🇺🇸United States
💳ARK Estimated Cost Average	🎫ARK Ownership Percent
$9.95 - ARKG$9.99 - ARKK	10.55%

Description
the organism company ginkgo bioworks engineers new organisms to solve challenges across a range of industries from fuels to pharmaceutical production. our biological engineers make use of an in-house pipeline of synthetic biology technologies to design, build, and test new organisms.
Website
ginkgobioworks.com

Ticker	Name	Weight

ARKG	ARK Genomic Revolution ETF	3.26%
ARKK	ARK Innovation ETF	1.89%
IBB	iShares Biotechnology ETF	0.06%

Combined Holdings of Ginkgo Bioworks (DNA) - Updated Daily

Trades of DNA Made In All Funds

Key Statistics

Other ETFs That Hold DNA

Research Notes and Commentary for DNA